Skip to main content

Table 1 Baseline characteristics of elderly patients with breast cancer before and after PSM

From: The trade-off of post-mastectomy radiotherapy usage for the breast cancer patients aged 70 years or older: a study based on SEER database

Characteristics

Before PSM

After PSM

 

Non-PMRT (N = 22,889)

PMRT (N = 4747)

P value

Non-PMRT (N = 3777)

PMRT (N = 3777)

P value

SMD

Age group at diagnosis, y

  

< 0.001

  

0.586

0.032

70–74

8028 (35.1)

1970 (41.5)

 

1476 (39.1)

1527 (40.4)

  

75–79

6634 (29.0)

1406 (29.6)

 

1123 (29.7)

1079 (28.6)

  

80–84

4869 (21.3)

883 (18.6)

 

745 (19.7)

731 (19.4)

  

85+

3358 (14.7)

488 (10.3)

 

433 (11.5)

440 (11.6)

  

Race

  

0.156

  

0.637

0.022

White

18,868 (82.4)

3906 (82.3)

 

3183 (84.3)

3154 (83.5)

  

Black

2054 (9.0)

460 (9.7)

 

346 ( 9.2)

358 (9.5)

  

Others

1967 (8.6)

381 (8.0)

 

248 ( 6.6)

265 (7.0)

  

Marital Status

  

< 0.001

  

0.981

0.001

Married

9252 (40.4)

2057 (43.3)

 

1547 (41.0)

1549 (41.0)

  

Unmarried

13,637 (59.6)

2690 (56.7)

 

2230 (59.0)

2228 (59.0)

  

Laterality

  

0.874

  

0.982

0.001

Left

11,821 (51.6)

2445 (51.5)

 

1959 (51.9)

1957 (51.8)

  

Right

11,068 (48.4)

2302 (48.5)

 

1818 (48.1)

1820 (48.2)

  

Grade

  

< 0.001

  

0.988

0.004

Grade I

4340 (19.0)

543 (11.4)

 

399 (10.6)

402 (10.6)

  

Grade II

10,491 (45.8)

2108 (44.4)

 

1694 (44.9)

1697 (44.9)

  

Grade III + IV

8058 (35.2)

2096 (44.2)

 

1684 (44.6)

1678 (44.4)

  

T

  

< 0.001

  

0.591

0.032

T0/T1

11,500 (50.2)

866 (18.2)

 

735 (19.5)

746 (19.8)

  

T2

9134 (39.9)

2197 (46.3)

 

1902 (50.4)

1859 (49.2)

  

T3

1395 (6.1)

1036 (21.8)

 

749 (19.8)

748 (19.8)

  

T4

860 (3.8)

648 (13.7)

 

391 (10.4)

424 (11.2)

  

N

  

< 0.001

  

0.506

0.035

N0

14,966 (65.4)

975 (20.5)

 

899 (23.8)

943 (25.0)

  

N1

5659 (24.7)

1685 (35.5)

 

1514 (40.1)

1465 (38.8)

  

N2

1460 (6.4)

1347 (28.4)

 

882 (23.4)

868 (23.0)

  

N3

804 (3.5)

740 (15.6)

 

482 (12.8)

501 (13.3)

  

ER

  

0.017

  

0.909

0.003

Negative

4462 (19.5)

998 (21.0)

 

776 (20.5)

771 (20.4)

  

Positive/Borderline

18,427 (80.5)

3749 (79.0)

 

3001 (79.5)

3006 (79.6)

  

PR

  

< 0.001

  

0.262

0.026

Negative

7549 (33.0)

1719 (36.2)

 

1365 (36.1)

1413 (37.4)

  

Positive/Borderline

15,340 (67.0)

3028 (63.8)

 

2412 (63.9)

2364 (62.6)

  

Chemotherapy

  

< 0.001

  

0.531

0.015

No/Unknown

18,902 (82.6)

2311 (48.7)

 

2157 (57.1)

2129 (56.4)

  

Yes

3987 (17.4)

2436 (51.3)

 

1620 (42.9)

1648 (43.6)

  

LN Surgery

     

0.145

0.034

SLNB

11,571 (50.6)

1198 (25.2)

< 0.001

1036 (27.4)

1094 (29.0)

  

ALND

11,318 (49.4)

3549 (74.8)

 

2741 (72.6)

2683 (71.0)

  
  1. PMRT = post-mastectomy radiotherapy; ER = estrogen receptor; PR = progesterone receptor; PSM = propensity score matching; SMD = standardized mean difference;
  2. LN = lymph node; SLNB = sentinel lymph node biopsy; ALND = axillary lymph node dissection